• Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Rating of "Buy" from Analysts

    Source: Buzz FX / 28 Jan 2025 07:26:18   America/Chicago


    Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Rating of "Buy" from Analysts Written by MarketBeat January 28, 2025 Share Link copied to clipboard. Shares of Cardiol Therapeutics Inc. ( NASDAQ:CRDL - Get Free Report ) have earned
    Read more...
Share on,